Examining fibromyalgia prevalence in elderly patients over 80
Frequency of Fibromyalgia Syndrome in Elderly Patients Aged 80 and Above and Its Relationship With Detailed Geriatric Assessment Parameters
This study looks at how common fibromyalgia is in people aged 80 and older to better understand their unique challenges and improve care for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 420 (estimated) |
| Ages | 80 Years and up |
| Sex | All |
| Sponsor | Sultan 1. Murat State Hospital Government |
| Locations | 1 site (Edirne) |
| Trial ID | NCT06969716 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine how common fibromyalgia syndrome is among patients aged 80 and older. It will involve a detailed geriatric assessment to explore the relationship between various geriatric parameters and the presence of fibromyalgia. By focusing on this specific age group, the study seeks to provide insights into the unique challenges faced by elderly patients with fibromyalgia. The findings could help improve understanding and management of fibromyalgia in older adults.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 80 and above who can undergo a detailed geriatric assessment.
Not a fit: Patients with neurodegenerative diseases, severe hearing loss, or those who have had recent acute illnesses will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and treatment of fibromyalgia in elderly patients, leading to better management of their symptoms.
How similar studies have performed: While studies on fibromyalgia exist, this specific focus on patients aged 80 and above is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 80 and above * Patients with complete detailed geriatric assessment parameters Exclusion Criteria: * Presence of neurodegenerative disease (dementia, parkinsonism) * Immobilized patient * Those who have had an acute illness (infection, fracture, cerebrovascular disease) in the last month * Having psychotic disorders * Having severe hearing loss
Where this trial is running
Edirne
- Sultan 1. Murat State Hospital — Edirne, Turkey (Recruiting)
Study contacts
- Principal investigator: Kübra Altunkalem Seydi, MD — Sultan 1. Murat State Hospital
- Study coordinator: Alper Mengi, MD
- Email: dralpmengi@gmail.com
- Phone: +90 537 651 03 85
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.